[PHARMA] QoQ TTM Result on 31-Dec-2020 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
17-Mar-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Dec-2020 [#4]
Profit Trend
QoQ- 118.99%
YoY- 118.42%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 4,737,880 3,230,009 2,698,649 2,725,071 2,806,171 2,898,216 2,854,343 40.14%
PBT 138,481 44,355 36,437 35,793 -189,175 -189,383 -191,228 -
Tax -58,488 -13,392 -9,755 -9,524 43,758 43,048 44,548 -
NP 79,993 30,963 26,682 26,269 -145,417 -146,335 -146,680 -
-
NP to SH 80,344 31,951 28,226 27,489 -144,778 -145,739 -146,437 -
-
Tax Rate 42.24% 30.19% 26.77% 26.61% - - - -
Total Cost 4,657,887 3,199,046 2,671,967 2,698,802 2,951,588 3,044,551 3,001,023 34.01%
-
Net Worth 391,428 357,275 355,919 337,298 345,040 357,891 350,047 7.72%
Dividend
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Div 58,895 36,634 23,534 28,740 26,125 22,204 22,188 91.59%
Div Payout % 73.30% 114.66% 83.38% 104.55% 0.00% 0.00% 0.00% -
Equity
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Net Worth 391,428 357,275 355,919 337,298 345,040 357,891 350,047 7.72%
NOSH 1,309,126 261,991 261,705 261,705 261,705 261,705 261,229 192.55%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 1.69% 0.96% 0.99% 0.96% -5.18% -5.05% -5.14% -
ROE 20.53% 8.94% 7.93% 8.15% -41.96% -40.72% -41.83% -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 361.91 246.81 1,031.18 1,042.20 1,073.54 1,109.43 1,092.66 -52.09%
EPS 6.14 2.44 10.79 10.51 -55.39 -55.79 -56.06 -
DPS 4.50 2.80 9.00 11.00 10.00 8.50 8.50 -34.53%
NAPS 0.299 0.273 1.36 1.29 1.32 1.37 1.34 -63.17%
Adjusted Per Share Value based on latest NOSH - 261,705
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 328.73 224.11 187.24 189.08 194.70 201.09 198.05 40.14%
EPS 5.57 2.22 1.96 1.91 -10.05 -10.11 -10.16 -
DPS 4.09 2.54 1.63 1.99 1.81 1.54 1.54 91.66%
NAPS 0.2716 0.2479 0.247 0.234 0.2394 0.2483 0.2429 7.72%
Price Multiplier on Financial Quarter End Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 -
Price 0.835 5.29 3.26 5.00 4.32 2.22 1.26 -
P/RPS 0.23 2.14 0.32 0.48 0.40 0.20 0.12 54.23%
P/EPS 13.61 216.68 30.23 47.56 -7.80 -3.98 -2.25 -
EY 7.35 0.46 3.31 2.10 -12.82 -25.13 -44.49 -
DY 5.39 0.53 2.76 2.20 2.31 3.83 6.75 -13.91%
P/NAPS 2.79 19.38 2.40 3.88 3.27 1.62 0.94 106.39%
Price Multiplier on Announcement Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 19/11/21 20/08/21 21/05/21 17/03/21 19/11/20 19/08/20 19/05/20 -
Price 0.845 0.925 4.03 3.49 5.72 4.42 1.88 -
P/RPS 0.23 0.37 0.39 0.33 0.53 0.40 0.17 22.30%
P/EPS 13.77 37.89 37.37 33.20 -10.33 -7.92 -3.35 -
EY 7.26 2.64 2.68 3.01 -9.68 -12.62 -29.82 -
DY 5.32 3.03 2.23 3.15 1.75 1.92 4.52 11.46%
P/NAPS 2.83 3.39 2.96 2.71 4.33 3.23 1.40 59.80%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment